1. Wang, Zhaowei, He, Lei, Li, Weina, Zhang, Cun, Li, Meng. . GDF15 induces immunosuppression via CD48 on regulatory T cells in hepatocellular carcinoma. In Journal for immunotherapy of cancer, 9, . doi:10.1136/jitc-2021-002787. https://pubmed.ncbi.nlm.nih.gov/34489334/
2. Kim-Muller, Ja Young, Song, LouJin, LaCarubba Paulhus, Brianna, Wu, Zhidan, Zhang, Bei B. 2023. GDF15 neutralization restores muscle function and physical performance in a mouse model of cancer cachexia. In Cell reports, 42, 111947. doi:10.1016/j.celrep.2022.111947. https://pubmed.ncbi.nlm.nih.gov/36640326/
3. Wang, Ying, Chen, Chaojie, Chen, Jiajun, Eling, Thomas, Wang, Xingya. 2022. Overexpression of NAG-1/GDF15 prevents hepatic steatosis through inhibiting oxidative stress-mediated dsDNA release and AIM2 inflammasome activation. In Redox biology, 52, 102322. doi:10.1016/j.redox.2022.102322. https://pubmed.ncbi.nlm.nih.gov/35504134/
4. Chen, Ruo-Yang, Li, Da-Wei, Xie, Hui, Zhang, Wei-Jie, Hou, Jian-Quan. 2023. Gene signature and prediction model of the mitophagy-associated immune microenvironment in renal ischemia-reperfusion injury. In Frontiers in immunology, 14, 1117297. doi:10.3389/fimmu.2023.1117297. https://pubmed.ncbi.nlm.nih.gov/37056767/
5. Chen, Jiajun, Peng, He, Chen, Chaojie, Eling, Thomas, Wang, Xingya. 2022. NAG-1/GDF15 inhibits diabetic nephropathy via inhibiting AGE/RAGE-mediated inflammation signaling pathways in C57BL/6 mice and HK-2 cells. In Life sciences, 311, 121142. doi:10.1016/j.lfs.2022.121142. https://pubmed.ncbi.nlm.nih.gov/36367498/